7 research outputs found

    Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Get PDF
    Stratification of women according to their risk of breast cancer based on polygenic risk scores (PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, optimized for prediction of estrogen receptor (ER)-specific disease, from the largest available genome-wide association dataset and to empirically validate the PRSs in prospective studies. The development dataset comprised 94,075 case subjects and 75,017 control subjects of European ancestry from 69 studies, divided into training and validation sets. Samples were genotyped using genome-wide arrays, and single-nucleotide polymorphisms (SNPs) were selected by stepwise regression or lasso penalized regression. The best performing PRSs were validated in an independent test set comprising 11,428 case subjects and 18,323 control subjects from 10 prospective studies and 190,040 women from UK Biobank (3,215 incident breast cancers). For the best PRSs (313 SNPs), the odds ratio for overall disease per 1 standard deviation in ten prospective studies was 1.61 (95%CI: 1.57-1.65) with area under receiver-operator curve (AUC) = 0.630 (95%CI: 0.628-0.651). The lifetime risk of overall breast cancer in the top centile of the PRSs was 32.6%. Compared with women in the middle quintile, those in the highest 1% of risk had 4.37- and 2.78-fold risks, and those in the lowest 1% of risk had 0.16- and 0.27-fold risks, of developing ER-positive and ER-negative disease, respectively. Goodness-of-fit tests indicated that this PRS was well calibrated and predicts disease risk accurately in the tails of the distribution. This PRS is a powerful and reliable predictor of breast cancer risk that may improve breast cancer prevention programs.NovartisEli Lilly and CompanyAstraZenecaAbbViePfizer UKCelgeneEisaiGenentechMerck Sharp and DohmeRocheCancer Research UKGovernment of CanadaArray BioPharmaGenome CanadaNational Institutes of HealthEuropean CommissionMinistĂšre de l'Économie, de l’Innovation et des Exportations du QuĂ©becSeventh Framework ProgrammeCanadian Institutes of Health Researc

    The BigDataEurope platform - supporting the variety dimension of big data

    No full text
    The management and analysis of large-scale datasets - described with the term Big Data - involves the three classic dimensions volume, velocity and variety. While the former two are well supported by a plethora of software components, the variety dimension is still rather neglected. We present the BDE platform - an easy-to-deploy, easy-to-use and adaptable (cluster-based and standalone) platform for the execution of big data components and tools like Hadoop, Spark, Flink, Flume and Cassandra. The BDE platform was designed based upon the requirements gathered from seven of the societal challenges put forward by the European Commission in the Horizon 2020 programme and targeted by the BigDataEurope pilots. As a result, the BDE platform allows to perform a variety of Big Data flow tasks like message passing, storage, analysis or publishing. To facilitate the processing of heterogeneous data, a particular innovation of the platform is the Semantic Layer, which allows to directly process RDF data and to map and transform arbitrary data into RDF. The advantages of the BDE platform are demonstrated through seven pilots, each focusing on a major societal challenge

    The Indolent B-Cell Lymphomas

    No full text

    The evolutionary ecology of fatty-acid variation : Implications for consumer adaptation and diversification

    No full text
    The nutritional diversity of resources can affect the adaptive evolution of consumer metabolism and consumer diversification. The omega-3 long-chain polyunsaturated fatty acids eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) have a high potential to affect consumer fitness, through their widespread effects on reproduction, growth and survival. However, few studies consider the evolution of fatty acid metabolism within an ecological context. In this review, we first document the extensive diversity in both primary producer and consumer fatty acid distributions amongst major ecosystems, between habitats and amongst species within habitats. We highlight some of the key nutritional contrasts that can shape behavioural and/or metabolic adaptation in consumers, discussing how consumers can evolve in response to the spatial, seasonal and community-level variation of resource quality. We propose a hierarchical trait-based approach for studying the evolution of consumers' metabolic networks and review the evolutionary genetic mechanisms underpinning consumer adaptation to EPA and DHA distributions. In doing so, we consider how the metabolic traits of consumers are hierarchically structured, from cell membrane function to maternal investment, and have strongly environment-dependent expression. Finally, we conclude with an outlook on how studying the metabolic adaptation of consumers within the context of nutritional landscapes can open up new opportunities for understanding evolutionary diversification

    The evolutionary ecology of fatty‐acid variation: Implications for consumer adaptation and diversification

    No full text

    Bond orientational order in liquids: Towards a unified description of water-like anomalies, liquid-liquid transition, glass transition, and crystallization

    No full text
    corecore